Leuprorelin vs treosulfan
Skin toxicity (alopecia)№ of participants: 73(1 RCT) · Platinum‐resistant and refractory (relapsed) epithelial ovarian cancer
It is very uncertain whether leuprorelin changes skin toxicity (alopecia)№ of participants: 73(1 RCT) compared with treosulfan (very low certainty).
1 finding from 1 review
- Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer 2016 · Cochrane Headline outcomes onlyRR 0.32 [0.12, 0.91]Studies not reportedVery low